The natural history of chronic allograft nephropathy BJ Nankivell, RJ Borrows, CLS Fung, PJ O'Connell, RDM Allen, ... New England Journal of Medicine 349 (24), 2326-2333, 2003 | 2443 | 2003 |
Improvement in outcomes of clinical islet transplantation: 1999–2010 FB Barton, MR Rickels, R Alejandro, BJ Hering, S Wease, B Naziruddin, ... Diabetes care 35 (7), 1436-1445, 2012 | 871 | 2012 |
Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology BJ Nankivell, RJ Borrows, CLS Fung, PJ O'Connell, JR Chapman, ... Transplantation 78 (4), 557-565, 2004 | 600 | 2004 |
Chronic renal allograft dysfunction JR Chapman, PJ O’Connell, BJ Nankivell Journal of the American society of nephrology 16 (10), 3015-3026, 2005 | 588 | 2005 |
Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes JE Gunton, RN Kulkarni, SH Yim, T Okada, WJ Hawthorne, YH Tseng, ... Cell 122 (3), 337-349, 2005 | 582 | 2005 |
Guidelines for the treatment and management of new‐onset diabetes after transplantation1 A Wilkinson, J Davidson, F Dotta, PD Home, P Keown, B Kiberd, ... Clinical transplantation 19 (3), 291-298, 2005 | 357 | 2005 |
Effect of histological damage on long-term kidney transplant outcome BJ Nankivell, CA Fenton-Lee, DRJ Kuypers, E Cheung, RDM Allen, ... Transplantation 71 (4), 515-523, 2001 | 333 | 2001 |
Natural history, risk factors, and impact of subclinical rejection in kidney transplantation BJ Nankivell, RJ Borrows, CLS Fung, PJ O’Connell, RDM Allen, ... Transplantation 78 (2), 242-249, 2004 | 327 | 2004 |
Hypoxia-inducible factor-1α regulates β cell function in mouse and human islets K Cheng, K Ho, R Stokes, C Scott, SM Lau, WJ Hawthorne, PJ O’connell, ... The Journal of clinical investigation 120 (6), 2171-2183, 2010 | 290 | 2010 |
Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts A Gougos, S St Jacques, A Greaves, PJ O'Connell, AJF d'Apice, ... International immunology 4 (1), 83-92, 1992 | 283 | 1992 |
Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the transplantion society working group CA Schinstock, RB Mannon, K Budde, AS Chong, M Haas, S Knechtle, ... Transplantation 104 (5), 911-922, 2020 | 202 | 2020 |
Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies MD Wavamunno, PJ O’connell, M Vitalone, CLS Fung, RDM Allen, ... American journal of transplantation 7 (12), 2757-2768, 2007 | 187 | 2007 |
Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010 AN Balamurugan, B Naziruddin, A Lockridge, M Tiwari, G Loganathan, ... American Journal of Transplantation 14 (11), 2595-2606, 2014 | 179 | 2014 |
Diabetic neuropathy after pancreas transplantation: determinants of recovery RDM Allen, IS Al-Harbi, JGL Morris, PD Clouston, PJ O'Connell, ... Transplantation 63 (6), 830-838, 1997 | 174 | 1997 |
Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras BJ Nankivell, CH P'Ng, PJ O'Connell, JR Chapman Transplantation 100 (8), 1723-1731, 2016 | 173 | 2016 |
Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year F Vincenti, HT Silva, S Busque, P O’connell, J Friedewald, D Cibrik, ... American journal of transplantation 12 (9), 2446-2456, 2012 | 172 | 2012 |
Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study PJ O'Connell, W Zhang, MC Menon, Z Yi, B Schröppel, L Gallon, Y Luan, ... The Lancet 388 (10048), 983-993, 2016 | 168 | 2016 |
Increasing access to integrated ESKD care as part of universal health coverage DCH Harris, SJ Davies, FO Finkelstein, V Jha, JA Donner, G Abraham, ... Kidney international 95 (4), S1-S33, 2019 | 166 | 2019 |
Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer–restricted CD4+ T cells infiltrate islets in type 1 diabetes V Pathiraja, JP Kuehlich, PD Campbell, B Krishnamurthy, T Loudovaris, ... Diabetes 64 (1), 172-182, 2015 | 160 | 2015 |
Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. PJ O'Connell, A Pacheco-Silva, PW Nickerson, RA Muggia, M Bastos, ... Journal of immunology (Baltimore, Md.: 1950) 150 (3), 1093-1104, 1993 | 159 | 1993 |